Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/28/2025

Sertraline and Escitalopram Comparison

Efficacy and Safety

  • The American College of Cardiology recommends sertraline for patients with established cardiovascular disease due to its well-studied cardiovascular safety profile and lower risk of QTc prolongation 5
  • The American Academy of Child and Adolescent Psychiatry suggests that both sertraline and escitalopram are appropriate options for patients aged 6 to 18 years with anxiety disorders, with close monitoring essential, especially in the first months of treatment and after dose adjustments 4, 1
  • Escitalopram has a lower propensity for drug interactions due to its minimal effects on CYP450 isoenzymes, making it preferable in patients taking multiple medications or elderly patients 4, 1
  • Sertraline may be more effective for managing psychomotor agitation and melancholia, although this evidence is limited 2, 3

Dosage and Administration

  • The American Academy of Child and Adolescent Psychiatry recommends that escitalopram can be administered once daily in all doses 1
  • Sertraline may require twice-daily dosing at low doses, especially in younger patients, although it is generally administered once daily due to its elimination half-life of 22-36 hours 4, 1

Special Populations

  • The American Heart Association suggests that sertraline is the preferred option in patients with coronary artery disease or heart failure due to its well-studied cardiovascular safety profile 5
  • Escitalopram may be preferable in elderly patients due to its lower potential for drug interactions 4, 1

Adverse Effects

  • Both medications share typical SSRI adverse effects, such as nausea, dry mouth, diarrhea, headache, somnolence, insomnia, sexual dysfunction, and behavioral activation/agitation 4, 1
  • The American Academy of Child and Adolescent Psychiatry notes that most adverse effects emerge in the first weeks of treatment and are generally mild and temporary 4, 1

Discontinuation and Switching

  • The American College of Cardiology recommends avoiding abrupt discontinuation of either medication 1
  • Monitoring for suicidal ideation is essential, especially in the first weeks and after dose changes 4, 1